T1	Participants 67 85	patients with GERD
T2	Participants 172 225	patients with gastroesophageal reflux disease (GERD).
T3	Participants 466 610	included adults with GERD-associated sleep disturbances and moderate-to-severe nighttime heartburn (recorded by patient diary during screening).
